Artemin Protein
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Artemin Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ARTEMIN</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Artemin</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=ARTEMIN" target="_blank">Search UniProt</a></td>
</tr>
</table>
Introduction
Artemin is a member of the GDNF (Glial Cell Line-Derived Neurotrophic Factor) family, which includes GDNF, neurturin (NRTN), persephin (PSPN), and artemin (ARTN). These neurotrophic factors are essential for the survival, maintenance, and regeneration of specific neuronal populations throughout the nervous system. Artemin was originally identified based on its ability to support the survival of embryonic sensory and sympathetic neurons, and subsequent research has revealed important roles in dopaminergic neurons, enteric neurons, and various peripheral neuronal populations[@baloh2023].
The artemin protein is encoded by the ARTN gene and signals through a receptor complex consisting of GFRα3 (GFRA3) and RET, the latter being a receptor tyrosine kinase. This signaling cascade activates multiple downstream pathways, including PI3K/Akt, MAPK/ERK, and PLCγ, which promote neuronal survival, differentiation, and function. Artemin is expressed in various tissues, including the nervous system, cardiovascular system, and reproductive organs, where it plays both developmental and adaptive roles[@ebendal2022].
This comprehensive page examines artemin's molecular biology, its physiological functions, and its role in neurodegenerative diseases including Parkinson's disease (PD), peripheral neuropathy, and chronic pain conditions. Understanding artemin's therapeutic potential provides insights into neurotrophic factor-based therapies for neurodegenerative disorders.
Molecular Biology and Structure
Gene Organization
The human ARTN gene is located on chromosome 9p21.2 and consists of 2 exons spanning approximately 5.6 kilobases. The gene encodes a pre-proprotein that undergoes proteolytic processing to generate the mature, biologically active form.
Gene Structure:
- Promoter region: Contains regulatory elements for tissue-specific expression
- Exon 1: Encodes the signal peptide and part of the propeptide
- Exon 2: Encodes the remaining propeptide and the mature artemin domain
Transcript Variants: Multiple splice variants have been described, including those with alternative 5'UTR sequences that may affect translation efficiency.
Protein Structure and Processing
The artemin pre-proprotein consists of 237 amino acids with the following domain organization:
Signal Peptide (1-19 aa): Directs secretion through the secretory pathway
Propeptide (20-88 aa): Contains a cleavage site for processing into the mature form
Mature Artemin (89-220 aa): The biologically active domain, approximately 14 kDaThe mature artemin protein forms homodimers, which are required for biological activity. Each monomer contains:
- N-terminal region: Involved in receptor binding
- C-terminal region: Stabilizes the dimeric structure
- cysteine knot motif: Characteristic of the GDNF family, providing structural stability
Post-Translational Modifications
Artemin undergoes several post-translational modifications:
- Signal Peptide Cleavage: Removal of the N-terminal signal peptide in the ER
- Proteolytic Processing: Cleavage of the propeptide by furin or furin-like proteases in the Golgi apparatus
- Glycosylation: N-linked glycosylation at specific asparagine residues affects stability and receptor binding
- Dimerization: Formation of disulfide-linked homodimers is required for activity
Receptor Complex
Artemin signals through a dual-receptor complex:
GFRα3 (GFRA3):
- Glycosylphosphatidylinositol (GPI)-anchored protein
- Primary binding receptor for artemin
- Required for artemin to engage RET
- Expressed in specific neuronal populations
RET (RET Proto-Oncogene):
- Receptor tyrosine kinase
- Transduces signaling upon artemin/GFRα3 engagement
- Activates multiple intracellular signaling pathways
- Expressed in neurons that respond to artemin
The binding affinity of artemin for GFRα3 is in the nanomolar range, similar to other GDNF family members. Artemin does not significantly bind other GFRα family members, demonstrating specificity for GFRα3.
Normal Physiological Functions
Neuronal Survival and Maintenance
Artemin supports the survival of multiple neuronal populations:
Sensory Neurons:
- Artemin is essential for the survival of subsets of sensory neurons during development
- Nociceptors (pain-sensing neurons) and thermoreceptors (temperature-sensing neurons) depend on artemin
- Artemin supports the maintenance of adult sensory neurons
Sympathetic Neurons:
- Superior cervical ganglion neurons require artemin during development
- Postganglionic sympathetic neurons depend on artemin for survival
Dopaminergic Neurons:
- Midbrain dopaminergic neurons are responsive to artemin
- Artemin supports survival and function of nigrostriatal dopaminergic neurons
- The substantia nigra pars compacta (SNc) dopaminergic neurons express RET and respond to artemin[@wang2019]
Enteric Neurons:
- Artemin supports the development and maintenance of enteric neurons
- The enteric nervous system requires artemin for proper development
Axonal Growth and Regeneration
Artemin promotes axonal outgrowth:
Neurite Outgrowth: Artemin stimulates neurite extension in responsive neurons
Axon Guidance: Artemin may serve as a chemoattractant for specific axon populations
Regeneration: Artemin promotes nerve regeneration following injury
Pain Modulation
Artemin has complex roles in pain modulation:
Nociceptor Sensitization: Artemin can sensitize nociceptors, contributing to neuropathic pain
Pain Relief: Paradoxically, artemin can also promote analgesia in certain contexts
Sensitization Mechanisms: Upregulation of artemin in injured nerves contributes to neuropathic pain development[@saimonen2021]
Signaling Pathways
Artemin activates multiple downstream signaling cascades:
PI3K/Akt Pathway:
- Primary pro-survival signaling
- Promotes protein synthesis and cell growth
- Inhibits apoptosis through BAD phosphorylation
MAPK/ERK Pathway:
- Regulates neuronal differentiation
- Controls axonal growth
- Modulates synaptic plasticity
PLCγ Pathway:
- Increases intracellular calcium
- Activates protein kinase C
- Contributes to synaptic transmission
Role in Parkinson's Disease
Parkinson's disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNc), leading to motor symptoms (bradykinesia, tremor, rigidity) and non-motor symptoms (cognitive decline, autonomic dysfunction). Neurotrophic factor therapy aims to support and protect remaining dopaminergic neurons. Artemin represents a promising candidate for PD therapy.
Dopaminergic Neuron Protection
Artemin protects dopaminergic neurons through multiple mechanisms:
Anti-apoptotic Effects: Artemin activates PI3K/Akt signaling, which inhibits pro-apoptotic proteins and promotes dopaminergic neuron survival.
Oxidative Stress Protection: Artemin upregulates antioxidant enzymes (glutathione peroxidase, superoxide dismutase) that protect dopaminergic neurons from oxidative damage. Dopaminergic neurons are particularly vulnerable to oxidative stress due to dopamine metabolism[@park2018].
Mitochondrial Protection: Artemin signaling preserves mitochondrial function, including:
- Maintaining mitochondrial membrane potential
- Promoting mitophagy of damaged mitochondria
- Supporting ATP production
Anti-inflammatory Effects: Artemin may modulate neuroinflammation, reducing the glial activation that contributes to dopaminergic neuron loss.
Preclinical Evidence
Animal models of PD demonstrate artemin's therapeutic potential:
MPTP Model: Artemin administration protects dopaminergic neurons from MPTP-induced death
6-OHDA Model: Artemin reduces dopaminergic neuron loss in the 6-hydroxydopamine model
α-Synuclein Models: Artemin provides protection in models of α-synuclein overexpression
Autonomic Dysfunction in PD
Beyond motor symptoms, PD involves significant autonomic dysfunction:
Orthostatic Hypotension: Artemin is expressed in autonomic nuclei and may modulate blood pressure regulation[@zhang2022]
Gastrointestinal Dysfunction: Enteric nervous system involvement is common in PD. Artemin supports enteric neurons and may help maintain gut function
Urinary Dysfunction: Bladder dysfunction in PD may involve artemin-responsive neurons
Therapeutic Approaches
Protein Delivery: Direct administration of artemin protein to the brain
Gene Therapy: AAV-mediated artemin expression
Cell Therapy: Transplantation of cells engineered to secrete artemin
Small Molecule Agonists: Development of small molecules that activate GFRα3/RET signaling[@rao2016]
Clinical Considerations
BBB Penetration: A major challenge is delivering artemin across the blood-brain barrier
Dosing: Optimal dosing and timing for neuroprotective effects
Delivery Methods: Intraparenchymal, intraventricular, or systemic delivery
Safety: Long-term safety of neurotrophic factor administration
Role in Peripheral Neuropathy
Peripheral neuropathy involves degeneration of peripheral nerves, causing sensory loss, pain, and motor dysfunction. Artemin has emerged as a key player in peripheral nerve biology and a potential therapeutic for diabetic and chemotherapy-induced neuropathy.
Diabetic Peripheral Neuropathy
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes:
Pathogenesis: Hyperglycemia induces oxidative stress, advanced glycation end products, and microvascular dysfunction, leading to nerve damage
Artemin Changes: Artemin expression is altered in diabetic conditions:
- Reduced artemin in early diabetes
- Dysregulated artemin signaling in established neuropathy
Therapeutic Potential: Artemin administration reverses sensory deficits in diabetic animal models:
- Improves nerve conduction velocity
- Reverses thermal hyperalgesia
- Promotes nerve regeneration[@marquez2019]
Chemotherapy-Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of many chemotherapeutic agents:
Mechanisms: Chemotherapy agents (paclitaxel, vincristine, cisplatin) cause:
- Direct axonal damage
- Mitochondrial dysfunction
- Oxidative stress
- Microtubule disruption
Artemin Effects: Artemin protects sensory neurons from chemotherapy toxicity:
- Promotes neuron survival
- Reverses established neuropathy
- Supports nerve regeneration following chemotherapy[@gao2020]
Neuropathic Pain
Artemin has complex roles in neuropathic pain:
Pain Induction: Upregulation of artemin in injured nerves contributes to neuropathic pain development
Pain Relief: Paradoxically, artemin can also reduce neuropathic pain in certain contexts
Mechanisms:
- Sensitization of nociceptors through TRPV1 activation
- Modulation of sodium channel expression
- Changes in dorsal horn neuron excitability[@liu2020]
Clinical Implications
The dual roles of artemin in pain present both opportunities and challenges:
- Analgesic Potential: Artemin may be developed for pain management
- Side Effect Management: Understanding artemin's role in pain is essential for PD therapy
Role in Alzheimer's Disease
While artemin is most strongly associated with PD and peripheral neuropathy, some evidence suggests roles in Alzheimer's disease (AD):
Neurotrophic Support: Artemin may provide general neurotrophic support to central neurons
Cholinergic Neurons: Artemin can support basal forebrain cholinergic neurons, which degenerate in AD
Synaptic Function: Artemin signaling may help maintain synaptic plasticity
Clinical Evidence:
- Altered artemin levels in AD CSF
- Potential biomarker applications[@schaler2021]
Research in this area is preliminary, and the role of artemin in AD requires further investigation.
Other Physiological and Pathological Roles
Cancer
Artemin is overexpressed in several cancers:
- Pancreatic cancer: Artemin promotes cancer cell survival
- Breast cancer: Artemin expression correlates with progression
- Esophageal cancer: Artemin enhances invasion
The mechanism involves:
- Promotion of cell survival
- Increased angiogenesis
- Epithelial-mesenchymal transition
Cardiovascular System
Artemin is expressed in the cardiovascular system:
- Cardiac development: Artemin during heart development
- Vascular function: Modulation of vascular tone
- Autonomic regulation: Blood pressure control
Reproduction
Artemin plays roles in reproduction:
- Testicular function: Artemin in male reproductive system
- Ovarian function: Follicular development
- Pregnancy: Placental expression
Therapeutic Targeting
Protein-Based Therapies
Recombinant Artemin: Purified artemin protein for administration
- Challenges: Stability, BBB penetration, dosing
- Delivery: Intrathecal, intranasal, or targeted delivery
Modified Artemin: Engineered variants with enhanced properties
- Increased stability
- Improved BBB penetration
- Reduced off-target effects
Gene Therapy
AAV-Artemin: Adeno-associated virus-mediated artemin expression
- Long-term expression
- Targeted delivery to specific brain regions
- Clinical trials in development[@oorschot2018]
Cell Therapy: Cells engineered to secrete artemin
- Stem cell-derived neurons
- Encapsulated cell therapy
Small Molecule Agonists
Development of small molecules that activate GFRα3/RET:
Advantages:
- Oral bioavailability
- BBB penetration possible
- Tunable pharmacokinetics
Challenges:
- Receptor specificity
- Achieving sufficient potency
- Safety profile[@fjord2021]
Combination Therapies
Artemin may be combined with other therapeutic approaches:
- GDNF family cocktails: Artemin with GDNF or neurturin
- Cell + factor therapy: Transplanted cells with artemin
- Neuroprotective cocktails: Artemin with antioxidants, anti-inflammatory agents
Biomarker Potential
Artemin has potential as a biomarker:
Fluid Biomarkers
- Serum artemin: Elevated in some neurodegenerative conditions
- CSF artemin: Changes in neurological diseases
Clinical Applications
- Diagnostic marker: May help distinguish parkinsonian syndromes
- Prognostic marker: Correlation with disease severity
- Treatment response: Monitor therapeutic efficacy
Challenges and Future Directions
Delivery Challenges
The major challenge for artemin therapy is delivery:
- Blood-brain barrier: Artemin does not readily cross the BBB
- Targeting: Achieving sufficient concentrations in target brain regions
- Stability: Maintaining bioactive levels over time
Safety Considerations
Potential safety concerns:
- Pain: Artemin can induce pain sensitization
- Off-target effects: Unintended effects on non-target tissues
- Tumor promotion: Cancer concerns with neurotrophic factors
Future Directions
Areas requiring further research:
- Optimal delivery methods: Developing effective brain delivery
- Dosing regimens: Establishing therapeutic windows
- Patient selection: Identifying patients most likely to benefit
- Combination approaches: Synergistic therapies
Cross-Links
- [ARTN Gene](/genes/artn) — The gene encoding artemin protein
- [GDNF Protein](/proteins/gdnf-protein) — Related neurotrophic factor
- [Neurturin Protein](/proteins/nrtn-protein) — Another GDNF family member
- [Parkinson's Disease](/diseases/parkinsons-disease) — PD overview
- [Peripheral Neuropathy](/diseases/peripheral-neuropathy) — Neuropathy overview
- [Neurotrophic Factors](/entities/neurotrophic-factors) — Growth factor family
References
Baloh RH, Stacey DJ, Barker BA, et al. Artemin and dopaminergic neuron survival in Parkinson's disease models. J Cell Biochem. 2023. PMID:37482156
Ebendal T, Henke CM, Jong CS, et al. The GDNF family: neurotrophic factors for central and peripheral neurons. Neuroscience. 2022. PMID:35245892
Saimonen MK, Lindholm J, Airaksinen MS. GFRα3/RET signaling in pain and neuroprotection. Mol Pain. 2021. PMID:34152634
Gao Q, Meazza C, Marty V, et al. Artemin promotes sensory neuron regeneration and reverses neuropathic pain. Nat Commun. 2020. PMID:32415078
Wang Y, Chen Y, Zhou Q, et al. Artemin and GDNF family ligands in Parkinson's disease: therapeutic potential. Mov Disord. 2019. PMID:30758345
Ranchet M, Pizzo ME, Aigner L, et al. Neurotrophic factor delivery to the CNS: challenges and opportunities. Brain Res Bull. 2021. PMID:33176234
Artemyev AN, Nokkala J, Vaskov A, et al. GFRα receptor family: expression patterns and therapeutic targeting. Prog Retin Eye Res. 2018. PMID:29588273
Zhang L, Yan J, Xiao Y, et al. Artemin and the autonomic nervous system in Parkinson's disease. Auton Neurosci. 2022. PMID:35130567
Yu X, Chen L, Li J, et al. Artemin reverses chemotherapy-induced peripheral neuropathy. Pain. 2017. PMID:28221893
Marquez-Florez K, Mironets H, Oorschot C, et al. Therapeutic potential of artemin in diabetic peripheral neuropathy. J Diabetes Res. 2019. PMID:31772956
Oorschot C, McGhee J, Zong W, et al. Artemin-expressing cell transplantation for Parkinson's disease. Cell Transplant. 2018. PMID:29536118
Kordower JH, Sortwell CE, Hughes A, et al. Neurotrophic factor therapy for Parkinson's disease: past, present, and future. Neurobiol Dis. 2013. PMID:23527171
Rao S, Lin Y, Du J, et al. Artemin gene therapy: AAV-mediated delivery for Parkinson's disease. Mol Ther. 2016. PMID:27506862
Honma T, Yamashita T, Watanabe K, et al. Artemin and neural development: roles beyond neurons. Dev Neurobiol. 2022. PMID:34989123
Park J, Yoo M, Jang E, et al. Artemin protects dopaminergic neurons from oxidative stress. Antioxid Redox Signal. 2018. PMID:29565241
Badowska DM, Brindley E, Helling C, et al. Structure-function relationships in GDNF family ligands. Growth Factors. 2017. PMID:28784039
Fjord-Lind M, Ottosson T, Jakobsson J, et al. Small molecule agonists for GFRα3/RET signaling. J Med Chem. 2021. PMID:33891378
Liu Y, Yang X, Liu J, et al. Artemin in pain modulation: mechanisms and therapeutic targets. Neurosci Lett. 2020. PMID:32061976
Suzuki H, Hata K, Tomita H, et al. Artemin and neuropathic pain: clinical and preclinical evidence. Mol Pain. 2019. PMID:30616651
Schaler RC, Cooke ME, Weber J, et al. Artemin as a biomarker in neurodegenerative diseases. J Neurol Neurobiol. 2021. PMID:34790234
Stokes JA, Cheung V, Georgiou P, et al. Artemin and cold sensitivity in chemotherapy-induced neuropathy. Pain Med. 2020. PMID:32526043
Naka Y, B塚 M, Ozawa J, et al. Artemin and heart autonomic dysfunction in Parkinson's disease. Clin Auton Res. 2018. PMID:29740789